PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Amerimmune, Fairfax, VA, USA.\', \'Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York City, NY, USA.\', \'S.U.N.Y. Downstate Health Sciences University, Brooklyn, NY, USA.\', \'Histogen, Inc, San Diego, CA, USA.\', \'Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/all.14907
?:hasPublicationType
?:journal
  • Allergy
is ?:pmid of
?:pmid
?:pmid
  • 33993490
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33993490>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33993490>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all